|
注册号: Registration number: |
ChiCTR2500107349 |
|
最近更新日期: Date of Last Refreshed on: |
2025-08-08 17:53:00 |
|
注册时间: Date of Registration: |
2025-08-08 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
50岁及以上人群艾滋病健康教育交互式数字干预方案的构建及实证研究 |
|
Public title: |
Development and Empirical Study of an Interactive Digital Intervention for HIV Health Education among Adults Aged 50 and Above |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
50岁及以上人群艾滋病健康教育交互式数字干预方案的构建及实证研究 |
|
Scientific title: |
Development and Empirical Study of an Interactive Digital Intervention for HIV Health Education among Adults Aged 50 and Above |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
彭文雯 |
研究负责人: |
彭文雯 |
|
Applicant: |
Peng Wenwen |
Study leader: |
Peng Wenwen |
|
申请注册联系人电话: Applicant telephone: |
+86 132 6076 0806 |
研究负责人电话:
Study leader's |
+86 132 6076 0806 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
pww1229@126.com |
研究负责人电子邮件: Study leader's E-mail: |
pww1229@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
研究负责人通讯地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
|
Applicant address: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan |
Study leader's address: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中南大学湘雅护理学院 |
||
|
Applicant's institution: |
Central South University, Xiangya School of Nursing |
||
|
研究负责人所在单位: |
中南大学湘雅护理学院 |
||
|
Affiliation of the Leader: |
Central South University, Xiangya School of Nursing |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
E2025125 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中南大学护理学院护理与行为医学研究伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethics Review Committee of Nursing and Behavioral Medicine Research, Xiangya School of Nursing, Central South University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-07-30 00:00:00 | ||
|
伦理委员会联系人: |
杨敏 |
||
|
Contact Name of the ethic committee: |
Yang Min |
||
|
伦理委员会联系地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
||
|
Contact Address of the ethic committee: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 180 7318 5501 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
yangminzhu@csu.edu.cn |
|
研究实施负责(组长)单位: |
中南大学湘雅护理学院 |
||||||||||||||||||||||
|
Primary sponsor: |
Central South University, Xiangya School of Nursing |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
海南省科学技术厅重点研发项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Key Research and development Project of Hainan Provincial Department of Science and Technology |
||||||||||||||||||||||
|
研究疾病: |
人类免疫缺陷病毒感染(HIV感染) |
||||||||||||||||||||||
|
Target disease: |
Human Immunodeficiency Virus (HIV) Infection |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
整群随机分组 |
||||||||||||||||||||||
|
Study design: |
Cluster randomization |
||||||||||||||||||||||
|
研究目的: |
本研究旨在开发一套适用于50岁及以上人群的艾滋病预防交互式数字健康干预方案,并基于整群随机对照试验评估其在提升艾滋病防治知识水平、安全套使用意图与行为、自我效能以及降低污名化与歧视态度等方面的干预效果。研究结果将为中老年人群艾滋病防控策略提供实证支持与实践路径。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to develop an interactive digital health intervention for HIV prevention among adults aged 50 years and older, and to evaluate its effectiveness through a cluster randomized controlled trial. The primary outcomes include improvements in HIV-related knowledge, condom use intention and behavior, self-efficacy, and reductions in stigma and discriminatory attitudes. The findings will provide empirical evidence and practical strategies for HIV prevention among the older adult population. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1、目前存在精神疾病、意识和沟通障碍; 2、正在参加其它类似项目者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Current mental illness, consciousness and communication disorders; 2. Those who are participating in other similar projects. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-08-08 00:00:00至 To 2027-01-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-08-08 00:00:00 至 To 2026-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机分组由项目组中未参与现场实施的研究人员负责,使用计算机随机数字表(如R语言中的sample()函数或Excel随机函数)生成随机序列。以社区为单位进行整群随机,将抽取的4个社区随机分配为干预组和对照组(各2个社区)。随机分组过程由独立第三方人员封存,研究实施人员在分配前不知晓分组结果。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The random allocation sequence will be generated by a research team member who is not involved in field implementation, using a computer-generated random number table (e.g., R software sample() function or Excel RAND function). Four selected communities will be randomly assigned into the intervention group (2 communities) and the control group (2 communities). The allocation sequence will be sealed and maintained by an independent staff member, and implementers will remain blinded to group assignment until allocation. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
临床试验公共管理平台 http://www.medresman.org.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Clinical Trial Management Public Platform http://www.medresman.org.cn |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究全部采用基于微信小程序的电子数据采集系统(Electronic Data Capture, EDC)进行数据收集与管理。所有问卷调查、行为日志和干预过程数据均通过小程序实时上传至安全的服务器数据库。研究团队通过权限分级管理和定期数据审核,确保数据的完整性、准确性和安全性。所有个人信息均经过匿名化处理,符合相关隐私保护法规。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This study employs a fully electronic data capture (EDC) system based on a WeChat mini-program for data collection and management. All questionnaire responses, behavioral logs, and intervention process data are uploaded in real-time to a secure server database via the mini-program. The research team implements role-based access control and conducts regular data audits to ensure data integrity, accuracy, and security. All personal information is anonymized in compliance with relevant privacy protection regulations. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |